Patents Assigned to CANDEL THERAPEUTICS, INC.
  • METHODS OF TREATING TIM-3 ELEVATION
    Publication number: 20210369837
    Abstract: The present disclosure provides formulations and therapies for treating subjects with elevated levels of TIM-3 using gene-based cytotoxic immunostimulant therapy alone or with other immunotherapies.
    Type: Application
    Filed: September 26, 2017
    Publication date: December 2, 2021
    Applicant: CANDEL THERAPEUTICS, INC.
    Inventors: Estuardo Aguilar-Cordova, Laura Kaye Aguilar, Antonio E. Chiocca, Brian Guzik, Sean Lawler, Maria Carmella Speranza